Article
28 Aug 2026
Drug Discovery In Space: How Microgravity Is Transforming Pharmaceutical Innovation
CONTRIBUTING SINCE APRIL 2012
Potter Clarkson
Potter Clarkson is one of Europe’s leading full-service IP law firms. Our IP attorneys and solicitors maximise the value of our clients' innovation by providing the experience, vision and clarity required to create, protect, leverage and defend their ideas in the most commercial and strategic ways all over the world.
POPULAR TOPICS
Intellectual Property
Food, Drugs, Healthcare, Life Sciences
Government, Public Sector
Media, Telecoms, IT, Entertainment
Corporate/Commercial Law
DETAILS
United Kingdom
+44 115 955 2211
The Belgrave Centre
Talbot Street
Nottingham
United Kingdom
Contact Firm
COMPANY CONTENT
Article
26 Aug 2026
EU AI Act Article 50: New AI Transparency Rules
Article
26 Aug 2026
EU Design Law Gets A Digital Upgrade
Article
20 Aug 2026
Priority Patent Applications For Biotech And Chemistry Startups
Article
19 Aug 2026
The Deal Killers Investors Often Find Too Late: An IP Lawyer’s Guide To Investor Readiness
Article
17 Aug 2026
HPV-positive Oropharyngeal Cancer: Prevention To Precision Treatment
Article
27 Jul 2026
Protecting Antibody Innovations Beyond Composition Claims
Article
24 Jul 2026
HPV Vaccine Success And The IP Opportunities Ahead
Article
15 Jul 2026
Fake Weight-Loss Medications And New Enforcement Possibilities
Article
07 Jul 2026
CJEU Rules On Hosting Defence For EU Platforms
Article
01 Jul 2026
Combination Therapies: IP Considerations For Synergistic Biologic Products
Article
30 Jun 2026
Perfect Storm - Four Drivers Behind The MRNA Litigation Wave
Article
24 Jun 2026
Patent Landscape And Freedom-to-operate Analysis For RNA-based Therapies: Identifying IP Risks Early
Article
18 Jun 2026
Kodak v FujiFilm: The Court Of Appeal Confirms UPC’s Long-arm Jurisdiction
Article
17 Jun 2026
Comparing EPC Article 53(a) And US Patent Law In Gene Editing Ethics
Article
14 Jun 2026
EPO Board Of Appeal Refers Claim Interpretation And Added Matter Questions
Article
10 Jun 2026
Creating An Effective IP Strategy For CAR-T
Article
08 Jun 2026
When Is A Synbio Company A Gene Therapy Company?
Article
26 May 2026
Drug Repurposing In The Age Of AI: Lessons From COVID-19 And The Future Of Second Medical Use Innovation
Article
26 May 2026
How To File An Opposition At The European Patent Office (EPO)
AWARDS
